This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: troponin

May 2019 Br J Cardiol 2019;26:59–62 doi:10.5837/bjc.2019.018

Rapid rule-out of NSTEMI: clinical characteristics and outcome of patients with undetectable troponin

Sally Youssef, Mariam Ali, Kim Heathcote, Alistair Mackay, Chris Isles

Abstract

Introduction Most patients presenting as an emergency with chest pain do not have myocardial infarction (MI),1 which must, nevertheless, be ruled out in order to reassure and discharge from hospital. High-sensitivity cardiac troponin T (hs-TnT) and troponin I (hs-TnI) have streamlined the assessment and management of chest pain, as a rapid rule out of MI is now possible, particularly if hs-TnT or hs-TnI are undetectable at presentation.2-8 Undetectable troponin cannot, however, be used to exclude unstable angina, which by definition is not associated with a troponin rise.9 It is for this reason that physicians and cardiologists may be reluct

| Full text
What next for troponin? When diagnostic precision muddies the water for the physician

January 2018 doi:10.5837/bjc.2018.003 Online First

What next for troponin? When diagnostic precision muddies the water for the physician

Thomas E Kaier

Abstract

(more…)

| Full text
Predicting long-term morbidity of ACS patients: can NT-proBNP succeed where other biomarkers have failed?

December 2014 Br J Cardiol 2014;21:147–52 doi:10.5837/bjc.2014.035

Predicting long-term morbidity of ACS patients: can NT-proBNP succeed where other biomarkers have failed?

Anna Kate Barton, Stephanie H Rich, Keith A A Fox

Abstract

Introduction For patients with acute coronary syndrome (ACS) who survive to reach hospital, the majority of mortality and morbidity over the following five years occurs after discharge.1 Of all complications, development of acute heart failure (AHF) and left ventricular systolic dysfunction (LVSD) are key determinants of adverse outcome. Approximately half of patients with ACS are readmitted to hospital, constituting a profound burden on healthcare resources.1 In several healthcare systems there are financial penalties when ACS patients are readmitted within 30 days.2 Prediction of the development of AHF and hospital readmission following ACS

| Full text
Troponin biomarkers: the benefits of echocardiography in a presumed diagnosis of NSTEMI

December 2014 Br J Cardiol 2014;21:160 doi:10.5837/bjc.2014.037

Troponin biomarkers: the benefits of echocardiography in a presumed diagnosis of NSTEMI

Mark R Jordan, Farhan Shahid, Richard P W Cowell

Abstract

(more…)

| Full text
High-sensitivity troponin T is detectable in most patients with clinically stable heart failure

March 2014 Br J Cardiol 2014;21:33–6 doi:10.5837/bjc.2014.005

High-sensitivity troponin T is detectable in most patients with clinically stable heart failure

Kristopher S Lyons, Gareth McKeeman, Gary E McVeigh, Mark T Harbinson

Abstract

(more…)

| Full text

August 2011 Br J Cardiol 2011;18:179

Correspondence

BJCardio Staff

Abstract

Amiodarone for the treatment of stable ventricular tachycardia – has the Resuscitation Council got it wrong? Dear Sirs, Amiodarone has been the UK Resuscitation Council’s recommendation for the treatment of haemodynamically stable ventricular tachycardia (VT) since 2000.1  It is my opinion that the evidence in support of amiodarone in this setting is poor and that superior agents may exist. In the last six years, three retrospective studies have been published showing a dismal success rate when amiodarone is used to treat patients with stable VT. Marill et al reported that eight out of 28 (29%) patients cardioverted using a dose of 150 m

| Full text
News from the American College of Cardiology Scientific Session 2011

June 2011 Br J Cardiol 2011;18:105–8

News from the American College of Cardiology Scientific Session 2011

BJCardio Staff

Abstract

PARTNER: transcatheter valves just as good as surgery for high risk aortic stenosis Transcatheter aortic valve implantation (TAVI) is just as effective at reducing mortality as surgery for severe aortic stenosis in elderly patients whose age and overall health posed high risks for conventional surgery, according to the results of the PARTNER (Placement of AoRTic TraNscathetER Valve trial). However, stroke rates were higher in the trancatheter group. The transcatheter approach involves delivering a bioprosthetic valve to its target location with a catheter using either transfemoral access or trans-apical access (through the ribs) if peripheral

| Full text

June 2011

Correspondence

Abstract

Chest pain – troponin and athletes Dear Sirs. We recently admitted two young men with chest discomfort suggestive of an acute coronary syndrome, who were troponin I positive. One was a 26-year-old Caucasian with left-sided chest heaviness engaging in regular triathlons. While serial resting electrocardiograms were unremarkable, troponin I on admission and one month later were elevated at 0.1 and 0.09 mg/L, respectively (normal range 0-0.04). An echocardiogram was entirely normal. An exercise treadmill stress test (ETT) was performed to 13 minutes (99% target heart rate achieved) of a Bruce protocol without symptoms or changes in the E

| Full text

March 2005 Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 9–AIC 14

Elevation of troponin I in acutely ill medical patients: a pilot study and literature review

Jonathan Watt, Andrew P Davie, Anne Cruickshank

Abstract

No content available

| Full text

January 2004 Br J Cardiol 2004;11:34-8

How do we define myocardial infarction? A survey of the views of consultant physicians and cardiologists

Julia Helen Baron, Alice Joy, Michael Millar-Craig

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now